Article

Rentschler Biopharma has appointed Dr. Veit Bergendahl as Chief Operating Officer, effective April 1, 2026. He will be responsible for process development, clinical and commercial cGMP manufacturing, engineering and technology, and production automation.

With over 20 years of international leadership experience in biopharmaceutical development and manufacturing, Dr. Bergendahl will help shape the company's strategy and drive sustainable growth.